I. Dougall

发表

QSAR and the rational design of long-acting dual D2-receptor/beta 2-adrenoceptor agonists.

R. Austin, P. Barton, A. Davis, 2003, Journal of medicinal chemistry.

Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages

I. Dougall, M. Ratcliffe, 2012, BMC Pharmacology and Toxicology.

Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists-discovery of AZD1981.

S. Teague, S. Thom, A. Cook, 2011, Bioorganic & medicinal chemistry letters.

Dual D2 Dopamine Receptor and β2-Adrenoceptor Agonists for the Modulation of Sensory Nerves in COPD

P. Newbold, A. Young, I. Dougall, 2001 .

Large-scale isolation of human skeletal muscle satellite cells from post-mortem tissue and development of quantitative assays to evaluate modulators of myogenesis

I. Scott, B. Isherwood, I. Dougall, 2013, Journal of cachexia, sarcopenia and muscle.

Isolation and characterisation of human pulmonary microvascular endothelial cells from patients with severe emphysema

J. Lordan, P. Corris, A. Fisher, 2013, Respiratory Research.

Duration of action of inhaled vs. Intravenous beta(2)-adrenoceptor agonists in an anaesthetized guinea-pig model.

A. Young, I. Dougall, S. Mohammed, 2000, Pulmonary pharmacology & therapeutics.

Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery

I. Dougall, K. McKechnie, S. Lydford, 1996, British journal of pharmacology.

Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages

I. Dougall, M. Ratcliffe, A. Walding, 2007, European Respiratory Journal.

Discovery of potent CRTh2 (DP2) receptor antagonists.

S. Teague, R. Weaver, S. Paine, 2006, Bioorganic & medicinal chemistry letters.

Switching between agonists and antagonists at CRTh2 in a series of highly potent and selective biaryl phenoxyacetic acids.

A. Davis, G. Pairaudeau, S. Thom, 2011, Bioorganic & medicinal chemistry letters.

Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airway diseases. 1. Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues.

R C Brown, A M Davis, W. T. Simpson, 1998, Journal of medicinal chemistry.

Lead generation using pharmacophore mapping and three-dimensional database searching: application to muscarinic M(3) receptor antagonists.

D R Flower, D. Flower, D P Marriott, 1999, Journal of medicinal chemistry.

From UTP to AR-C118925, the discovery of a potent non nucleotide antagonist of the P2Y2 receptor.

Michael J. Stocks, N. Kindon, I. Dougall, 2017, Bioorganic & medicinal chemistry letters.

Dual dopamine D2 receptor and beta2-adrenoceptor agonists for the treatment of chronic obstructive pulmonary disease: the pre-clinical rationale.

D. Jackson, A. Young, I. Dougall, 2003, Respiratory medicine.

FUNCTIONAL METHODS FOR QUANTIFYING AGONISTS AND ANTAGONISTS

Iain G. Dougall, I. Dougall, 2001, Journal of receptor and signal transduction research.

Evaluation of the Biological Activity of Compounds: Techniques and Mechanism of Action Studies

J. Unitt, I. Dougall, 2015 .

Differential gene expression analysis in human monocyte-derived macrophages: impact of cigarette smoke on host defence.

Michael Dymond, Philip Shelton, Ian Doyle, 2010, Molecular immunology.

Agonist-antagonist interactions at angiotensin receptors: application of a two-state receptor model.

M. J. Robertson, P. Leff, I. Dougall, 1994, Trends in pharmacological sciences.

Further concerns over Cheng-Prusoff analysis.

P. Leff, I. Dougall, I. Dougall, 1993, Trends in pharmacological sciences.

Differential gene expression analysis in human monocyte-derived macrophages: impact of cigarette smoke on host defence.

I. Dougall, M. Ratcliffe, A. Walding, 2010, Molecular immunology.